Eloxx Pharmaceuticals (ELOX) Reports Q2 Loss of $0.42/Share

Go back to Eloxx Pharmaceuticals (ELOX) Reports Q2 Loss of $0.42/Share
(NASDAQ: ELOX) Delayed: 18.76 -0.31 (1.63%)
Previous Close $19.07    52 Week High
Open $19.23    52 Week Low
Day High $19.23    P/E N/A 
Day Low $17.17    EPS
Volume 29,638